MediPharm Labs Corp. (LABS.TO)
CAD 0.06
(-7.69%)
CAD 0.06
(-7.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -11.76 Million | -16.06 Million | -13.21 Million | -37.77 Million | -25.26 Million | -11.11 Million |
| Net Income | -13.08 Million | -29.98 Million | -54.8 Million | -67.11 Million | 1.13 Million | -8.46 Million |
| Depreciation & Amortization | 2.51 Million | 2.87 Million | 5.63 Million | 10.8 Million | 2.53 Million | 982 Thousand |
| Deferred income taxes | -2.69 Million | -6000.00 | 113 Thousand | -4.87 Million | 5.62 Million | - |
| Stock-based compensation | 2.02 Million | 2.87 Million | 2.4 Million | 2.68 Million | 15.5 Million | 1.96 Million |
| Change in working capital | 3.45 Million | 6.24 Million | 21.82 Million | 17.06 Million | -50.23 Million | -11.22 Million |
| Other non-cash items | -3.98 Million | 1.93 Million | 11.61 Million | 3.65 Million | 186 Thousand | 5.63 Million |
| Investing Cash Flow | 6.87 Million | 5.15 Million | 35 Thousand | -7.44 Million | -32.54 Million | -14.6 Million |
| Investments in PPE | -471 Thousand | -863 Thousand | -783 Thousand | -7.5 Million | -32.43 Million | -14.57 Million |
| Acquisitions | 7.34 Million | 6.01 Million | 818 Thousand | -540.99 Thousand | - | - |
| Investment purchases | - | - | - | -2000.00 | -108 Thousand | -31 Thousand |
| Sales/Maturities of investments | - | - | - | 540.99 Thousand | - | - |
| Other Investing Activities | 1.9 Million | 7000.00 | 507 Thousand | 59 Thousand | -108 Thousand | -31 Thousand |
| Financing Cash Flow | -944 Thousand | 796 Thousand | 27.8 Million | 26.42 Million | 88.49 Million | 31.06 Million |
| Debt repayment | -696 Thousand | -948 Thousand | -2.96 Million | -14.06 Million | -6.19 Million | -6 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 30.91 Million | 41.44 Million | 70.82 Million | 24.29 Million |
| Other Financing Activities | 840 Thousand | 1.74 Million | -151 Thousand | -965 Thousand | 23.87 Million | 6.76 Million |
| Accounts receivables | 6.42 Million | 3.61 Million | 12.72 Million | -2.08 Million | -19.55 Million | -6.42 Million |
| Accounts payables | -5.16 Million | 1.49 Million | -8.1 Million | -4.57 Million | 11.23 Million | 6.88 Million |
| Inventory | 3.11 Million | -103 Thousand | 11.16 Million | 29.4 Million | -42.08 Million | -9.4 Million |
| Other working capital | -918 Thousand | 1.23 Million | 6.04 Million | -5.68 Million | 159 Thousand | -2.27 Million |
| Cash at beginning of period | 24.14 Million | 34.11 Million | 19.91 Million | 38.62 Million | 7.85 Million | 2.49 Million |
| Cash at end of period | 17.98 Million | 24.14 Million | 34.11 Million | 19.91 Million | 38.62 Million | 7.85 Million |
| Capital Expenditure | -471 Thousand | -863 Thousand | -783 Thousand | -7.5 Million | -32.43 Million | -14.57 Million |
| Effect of forex changes on cash | -329 Thousand | 150 Thousand | -429 Thousand | 83 Thousand | 89 Thousand | 9000.00 |
| Net cash flow / Change in cash | -6.16 Million | -9.96 Million | 14.19 Million | -18.71 Million | 30.77 Million | 5.35 Million |
| Free Cash Flow | -12.23 Million | -16.93 Million | -13.99 Million | -45.27 Million | -57.7 Million | -25.68 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.58 Million | -3.61 Million | -13.08 Million | -2.96 Million | -4.32 Million | -2.7 Million |
| Depreciation & Amortization | 731 Thousand | 790 Thousand | 2.51 Million | 717 Thousand | 617 Thousand | 692 Thousand |
| Deferred income taxes | - | - | -2.69 Million | 4.99 Million | 382 Thousand | 784 Thousand |
| Stock-based compensation | 576 Thousand | 895 Thousand | 2.02 Million | 306 Thousand | 386 Thousand | 588 Thousand |
| Change in working capital | -575 Thousand | 528 Thousand | 3.45 Million | 5.17 Million | -1.35 Million | -952 Thousand |
| Other non-cash items | 2.61 Million | 1.36 Million | -3.98 Million | -6.59 Million | 1.06 Million | -5.93 Million |
| Investing Cash Flow | -35 Thousand | 525 Thousand | 6.87 Million | 4.3 Million | 1.64 Million | 946 Thousand |
| Investments in PPE | -56 Thousand | -21 Thousand | -471 Thousand | -119 Thousand | -260 Thousand | -67 Thousand |
| Acquisitions | 21 Thousand | 546 Thousand | 7.34 Million | 4.42 Million | 1.9 Million | 1.01 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -35 Thousand | 220 Thousand | 1.9 Million | 4.42 Million | 1.9 Million | 1.00 |
| Financing Cash Flow | 596 Thousand | -269 Thousand | -944 Thousand | -391 Thousand | -299 Thousand | 1.09 Million |
| Debt repayment | -639 Thousand | -217 Thousand | -696 Thousand | -321 Thousand | -387 Thousand | -67 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 200 Thousand | 224 Thousand | 840 Thousand | 227 Thousand | 88 Thousand | 1.15 Million |
| Accounts receivables | 319 Thousand | -616 Thousand | 6.42 Million | 5.77 Million | -230 Thousand | 900 Thousand |
| Accounts payables | -601 Thousand | 1.88 Million | -5.16 Million | -1.26 Million | -1.2 Million | -1.9 Million |
| Inventory | 37 Thousand | -80 Thousand | 3.11 Million | 2.22 Million | -416 Thousand | 106 Thousand |
| Other working capital | -330 Thousand | -660 Thousand | -918 Thousand | -1.56 Million | 492 Thousand | -54 Thousand |
| Cash at beginning of period | 16.92 Million | 17.98 Million | 24.14 Million | 12.95 Million | 14.74 Million | 20.15 Million |
| Cash at end of period | 15.99 Million | 16.92 Million | 17.98 Million | 17.98 Million | 12.95 Million | 14.74 Million |
| Capital Expenditure | -56 Thousand | -21 Thousand | -471 Thousand | -119 Thousand | -260 Thousand | -67 Thousand |
| Effect of forex changes on cash | 21 Thousand | 12 Thousand | -329 Thousand | -510 Thousand | 96 Thousand | 85 Thousand |
| Net cash flow / Change in cash | -935 Thousand | -1.05 Million | -6.16 Million | 5.03 Million | -1.79 Million | -5.4 Million |
| Free Cash Flow | -1.57 Million | -1.34 Million | -12.23 Million | 1.5 Million | -3.49 Million | -7.59 Million |
TBEV
MVP
002824
UPPR
TANA
600211